Picture of Mycelx Technologies logo

MYX Mycelx Technologies News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsHighly SpeculativeMicro CapNeutral

REG - MyCelx Tech. Corp. MyCelx Tech. Corp.. - Grant of Options




 



RNS Number : 3352V
MyCelx Technologies Corporation
13 April 2021
 

13 April 2021

 

MYCELX Technologies Corporation

 

("MYCELX" or the "Company") (AIM: MYX)

 

Grant of Options

 

The Company announces the grant of share options over the Company's common shares of US$0.025 each ("Common Shares") under the 2011 MYCELX Omnibus Performance Incentive Plan which was extended at the 2019 Annual Meeting (the "Plan").

 

Details of the awards to Directors and a PDMR on 12 April 2021 together with their current beneficial holding of Common Shares are presented in the following below:

 

Grant of Share Options to Chief Financial Officer

 

 

Name

Number of share options granted

Exercise price

Total number of share options held following this notification

Total number of share options as % of current issued share capital






Kimberly Slayton

140,000

US$0.69*

270,000

1.39%

 

Ms. Slayton holds no Common Shares in the issued capital of the Company.

 

Grant of Share Options to President and Chief Science Officer

 

 

Name

Number of share options granted

Exercise price

Total number of share options held following this notification

Total number of share options as % of current issued share capital






Haluk Alper

70,000

US$0.69*

124,339

0.64%

 

In addition, following this award, Mr. Alper continues to be interested in 1,262,046 Common Shares, representing 6.49 per cent of the present issued capital of the Company.

 

Grant of Share Options to Chief Executive Officer

 

 

Name

Number of share options granted

Exercise price

Total number of share options held following this notification

Total number of share options as % of current issued share capital






Connie Mixon

210,000

US$0.69*

413,017

2.12%

 

In addition, following this award, Connie Mixon continues to be interested in 2,480,469 Common Shares, representing 12.76 per cent of the present issued capital of the Company.

 

The aggregate number of Common Shares held by Ms. Mixon also includes (a) 150,000 shares held by limited liability companies controlled by Ms. Mixon; and (b) 202,646 shares held by or on behalf of Ms. Mixon's children.

 

The above grants formed part of wider grants of, in aggregate, 769,000 options to employees across the Company, on the same date, representing 3.95% of the current issued share capital. 

 

These share options granted on 12 April 2021 will vest as to one third equally on 12 April 2021, 12 April 2022 and 12 April 2023, and must be exercised prior to the tenth anniversary of the date of grant, subject to the restrictions on dealing under the Company's share dealing code.

 

Following the above grants, a total of 2,038,338 share options have been granted to directors and employees and are currently outstanding, representing 10.48% of the issued share capital of 19,443,750 Common Shares.

 

*Based on the closing mid-market price of the Company's Common Shares at 12 April 2021, and the closing US/£ exchange rate at that date.

 

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Canaccord Genuity, Nominated Adviser

Henry Fitzgerald-O'Connor

Georgina McCooke

 

 

Tel: + 44 20 7523 8000

Celicourt

Mark Antelme

Jimmy Lea

 

Tel: +44 20 8434 2754

 

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation (No. 596/2014).

Notification of transactions of persons discharging managerial responsibility or connected persons

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Connie Mixon

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MYCELX Technologies Corporation

b)

 

LEI

 

 

213800UJZINIK2VD1G48

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Common shares of US$0.025

 

 

USU624551078

 

 

b)

 

Nature of the transaction

 

 

Grant of share option to Connie Mixon under the MYCELX Omnibus Performance Incentive Plan

 

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

US$0.69

 

210,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

n/a

 

 

n/a

 

 

e)

 

Date of the transaction

 

 

12/04/2021

f)

 

Place of the transaction

 

 

 Grant of the options occurred outside a trading venue.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kimberly Slayton

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MYCELX Technologies Corporation

b)

 

LEI

 

 

213800UJZINIK2VD1G48

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Common shares of US$0.025

 

USU624551078

 

 

b)

 

Nature of the transaction

 

 

Grant of share option to Kimberly Slayton under the MYCELX Omnibus Performance Incentive Plan

 

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

US$0.69

 

140,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

n/a

 

 

n/a

 

 

e)

 

Date of the transaction

 

 

12/04/2021

f)

 

Place of the transaction

 

 

 Grant of the options occurred outside a trading venue.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Haluk Alper

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MYCELX Technologies Corporation

b)

 

LEI

 

 

213800UJZINIK2VD1G48

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Common shares of US$0.025

 

USU624551078

 

 

b)

 

Nature of the transaction

 

 

Grant of share option to Haluk Alper under the MYCELX Omnibus Performance Incentive Plan

 

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

US$0.69

 

70,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

n/a

 

 

n/a

 

 

e)

 

Date of the transaction

 

 

12/04/2021

f)

 

Place of the transaction

 

 

 Grant of the options occurred outside a trading venue.

 

 

 

Notes to Editors

Through its revolutionary oil-free water technology, MYCELX brings its customers material benefits in terms of performance enhancement, cost savings and significantly improved environmental footprints. Working beyond any ordinary filtration methods, MYCELX's proprietary technology achieves oil removal to less than one part per million.  MYCELX supports leading international customers across the oil & gas value chain, as well as other industrial users.   MYCELX also provides advanced air filtration technology for manufacturing and industrial facilities, effectively removing oil particles and biologicals to maintain continuous and safe air quality levels.

For more information, visit www.MYCELX.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFSFSSIVLIL

Recent news on Mycelx Technologies

See all news